TelesisBio_Logo_RGB.png
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 16:05 ET | Telesis Bio
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
TelesisBio_Logo_RGB.png
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
February 26, 2024 09:15 ET | Telesis Bio
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
TelesisBio_Logo_RGB.png
Telesis Bio Reports Third Quarter 2023 Financial Results
November 13, 2023 16:22 ET | Telesis Bio
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter...
TelesisBio_Logo_RGB.png
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
November 07, 2023 09:00 ET | Telesis Bio
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023...
TelesisBio_Logo_RGB.png
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
November 03, 2023 12:00 ET | Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
TelesisBio_Logo_RGB.png
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
September 28, 2023 15:48 ET | Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
TelesisBio_Logo_RGB.png
Telesis Bio Appoints William J. Kullback Chief Financial Officer
August 29, 2023 16:05 ET | Telesis Bio
SAN DIEGO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial...
TelesisBio_Logo_RGB.png
Telesis Bio Reports Second Quarter 2023 Financial Results
August 10, 2023 16:05 ET | Telesis Bio
SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the second...
TelesisBio_Logo_RGB.png
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
August 03, 2023 17:00 ET | Telesis Bio
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its second quarter...
TelesisBio_Logo_RGB.png
Telesis Bio to Present at Jefferies Healthcare Conference 2023
June 08, 2023 09:05 ET | Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...